Impact of adalimumab therapy on bone metabolism in Crohn's disease patients: A 3 months follow up study

被引：0
|
作者：
Veerappan, S. G. [1 ]
Healy, M. [2 ]
Walsh, B.
Kennedy, M. [3 ,4 ]
O'Morain, C. A. [4 ]
Ryan, B. M. [4 ]
Daly, J. S. [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dept Anat, Div Biol, Dublin 2, Ireland
[2] St James Hosp, Dept Biochem, Dublin 8, Ireland
[3] St James Hosp, Dept Gerontol, Dublin 8, Ireland
[4] Adelaide & Meath Hosp, Dept Gastroenterol, Dublin, Ireland
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [11] Adalimumab therapy in Crohn's disease of the ileal pouch
    Li, Yue
    Lopez, Rocio
    Queener, Elaine
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2232 - 2239
  • [12] Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
    Lichtenstein, Gary R.
    Thomsen, Ole O.
    Schreiber, Stefan
    Lawrance, Ian C.
    Hanauer, Stephen B.
    Bloomfield, Ralph
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (07) : 600 - 609
  • [13] Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab
    Shafran, I
    Burgunder, P.
    Fakih, A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S44 - S44
  • [14] Adherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn's Disease
    Liu, Yifei
    Soderberg, Joakim
    Chao, Jingdong
    PHARMACY, 2022, 10 (04)
  • [15] Adalimumab maintenance therapy improves quality of life in patients with Crohn's disease
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 (3) : 129 - 129
  • [16] Improvement of bone metabolism after infliximab therapy in Crohn's disease
    Miheller, P
    Muzes, G
    Zagoni, T
    Toth, M
    Tulassay, Z
    GASTROENTEROLOGY, 2004, 126 (04) : A470 - A471
  • [17] Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease
    Miheller, Pal
    Muzes, Gyorgyi
    Zagoni, Tamas
    Toth, Miklos
    Racz, Karoly
    Tulassay, Zsolt
    DIGESTIVE DISEASES, 2006, 24 (1-2) : 201 - 206
  • [18] Impact of Patient Weight on Adalimumab Efficacy in Crohn's Disease - A Pilot Study
    Al-Taweel, Talal
    Kopylov, Uri
    Strohl, Matthew
    Paradis-Surprenant, Laurence
    Almaimani, Mohanad K.
    Martel, Myriam
    Bitton, Alain
    Afif, Waqqas
    Bessissow, Talat
    Seidman, Ernest G.
    GASTROENTEROLOGY, 2014, 146 (05) : S459 - S459
  • [19] Observational Study of Treatment Patterns in Patients Newly Initiated with Adalimumab or Infliximab Therapy for Crohn's Disease
    Plevy, Scott
    Lu, M.
    Yu, Andrew
    Sharma, Hari
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S479 - S479
  • [20] Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry
    D'Haens, Geert
    Reinisch, Walter
    Panaccione, Remo
    Satsangi, Jack
    Petersson, Joel
    Bereswill, Mareike
    Arikan, Dilek
    Perotti, Eva
    Robinson, Anne M.
    Kalabic, Jasmina
    Alperovich, Gabriela
    Thakkar, Roopal
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (06): : 872 - 882
12345